BiotechTube
Home/Vyluma/Tung M. Fong, PhD
TM

Tung M. Fong, PhD

Vice President, Clinical Development

Vyluma

Therapeutic Areas

OphthalmologyPediatric MyopiaRefractive Errors

Vyluma Pipeline

DrugIndicationPhase
NVK002Pediatric Myopia (progression)Phase 3
NVK029PresbyopiaPhase 2
NVK031Night Vision DisturbanceProof-of-Concept

Leadership Team at Vyluma

GZ
George Zorich
Chairman & CEO
HH
Houman Hemmati, MD, PhD
Chief Medical Affairs Officer
View full Vyluma profile